Literature DB >> 27816114

Integrated Imaging in Hypertrophic Cardiomyopathy.

Lubna Choudhury1, Vera H Rigolin2, Robert O Bonow2.   

Abstract

Hypertrophic cardiomyopathy (HC) has a very heterogeneous clinical spectrum and lends itself to multimodality imaging for evaluation and management. This review addresses clinical applications of cardiac imaging in patients with HC. Integrating various techniques of echocardiography and cardiac magnetic resonance (CMR) is discussed in the clinical context such as diagnosis, evaluation, management, risk stratification, and family screening of patients with HC. The utility of periprocedural imaging techniques is highlighted for guiding surgical and transcatheter septal reduction procedures. More limited roles of invasive or computed tomography coronary angiography are discussed for patients with HC with chest pain and risk factors for coronary artery disease. Nuclear techniques although available for decades play a more limited role in contemporary routine management but may assist in risk assessment. Newer CMR and echo imaging techniques are discussed in their emerging roles for further characterization of patients with HC and family members with prospects of preclinical diagnosis. The strengths of the different imaging modalities are presented as well as a flow diagram summarizing integrated imaging in this disease. In conclusion, integrated imaging using the various imaging techniques predominantly echocardiography and CMR based on the clinical picture plays an essential role in the management of patients with HC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27816114     DOI: 10.1016/j.amjcard.2016.09.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Risk stratification in hypertrophic cardiomyopathy.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; S Kachboura
Journal:  Herz       Date:  2018-04-25       Impact factor: 1.443

2.  Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Hideaki Yuki; Daisuke Utsunomiya; Shinya Shiraishi; Seiji Takashio; Fumi Sakamoto; Noriko Tsuda; Seitaro Oda; Masafumi Kidoh; Takeshi Nakaura; Kenichi Tsujita; Yasuyuki Yamashita
Journal:  Heart Vessels       Date:  2017-12-11       Impact factor: 2.037

3.  High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  D H Frank Gommans; G Etienne Cramer; Jeannette Bakker; Hendrik-Jan Dieker; Michelle Michels; Michael A Fouraux; Carlo L M Marcelis; Freek W A Verheugt; Janneke Timmermans; Marc A Brouwer; Marcel J M Kofflard
Journal:  Int J Cardiovasc Imaging       Date:  2017-10-23       Impact factor: 2.357

4.  Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Monika Gawor; Agata Kubik; Ewa Kowalik; Barbara Miłosz-Wieczorek; Maciej Dąbrowski; Konrad Werys; Łukasz Mazurkiewicz; Katarzyna Kożuch; Magdalena Polańska-Skrzypczyk; Joanna Petryka-Mazurkiewicz; Anna Klisiewicz; Zofia T Bilińska; Jacek Grzybowski; Adam Witkowski; Magdalena Marczak
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-21       Impact factor: 5.364

Review 5.  Differential diagnosis of thickened myocardium: an illustrative MRI review.

Authors:  Cristina Méndez; Rafaela Soler; Esther Rodríguez; Roberto Barriales; Juan Pablo Ochoa; Lorenzo Monserrat
Journal:  Insights Imaging       Date:  2018-10-09

Review 6.  Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings.

Authors:  Rafaela Soler; Cristina Méndez; Esther Rodríguez; Roberto Barriales; Juan Pablo Ochoa; Lorenzo Monserrat
Journal:  Insights Imaging       Date:  2018-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.